Cargando…

MSH6 syndrome

Detalles Bibliográficos
Autores principales:	Suchy, Janina, Lubiński, Jan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735474/ https://www.ncbi.nlm.nih.gov/pubmed/19804606 http://dx.doi.org/10.1186/1897-4287-6-2-103

Ejemplares similares

MSH2 and MLH1 testing
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients
por: Rashid, Muhammad Usman, et al.
Publicado: (2019)

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern
por: Wiesendanger, Margrit, et al.
Publicado: (2000)

Lynch syndrome (HNPCC)
por: Kładny, Józef, et al.
Publicado: (2008)

Prerecognition Diffusion Mechanism of Human DNA Mismatch Repair Proteins along DNA: Msh2-Msh3 versus Msh2-Msh6
por: Pal, Arumay, et al.
Publicado: (2020)

The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers
por: Lawes, D A, et al.
Publicado: (2005)

A Role for Msh6 But Not Msh3 in Somatic Hypermutation and Class Switch Recombination
por: Martomo, Stella A., et al.
Publicado: (2004)

Parameters of Reserpine Analogs That Induce MSH2/MSH6-Dependent Cytotoxic Response
por: Vasilyeva, Aksana, et al.
Publicado: (2010)

Mismatch Recognition by Saccharomyces cerevisiae Msh2-Msh6: Role of Structure and Dynamics
por: Li, Yan, et al.
Publicado: (2019)

UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families
por: Grandval, Philippe, et al.
Publicado: (2013)

An unusual tumor spectrum in Lynch syndrome caused by MSH6 mutation
por: Perrier, Renee L, et al.
Publicado: (2010)

Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome
por: Liccardo, Raffaella, et al.
Publicado: (2017)

Cadmium inhibits mismatch repair by blocking the ATPase activity of the MSH2–MSH6 complex
por: Banerjee, Sreeparna, et al.
Publicado: (2005)

Cadmium inhibits mismatch repair by blocking the ATPase activity of the MSH2–MSH6 complex
por: Banerjee, Sreeparna, et al.
Publicado: (2005)

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
por: Pritchard, Colin C., et al.
Publicado: (2014)

Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair
por: DuPrie, Matthew L., et al.
Publicado: (2022)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
por: Schneider, Nayê Balzan, et al.
Publicado: (2018)

Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas
por: Ericson, Kajsa, et al.
Publicado: (2004)

Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families
por: Thodi, Georgia, et al.
Publicado: (2010)

Identification of new genetic alterations in MLH1, MSH2 and MSH6 using IHC and HRM analysis in Lynch syndrome-suspected patients
por: Mazurek, A, et al.
Publicado: (2012)

The Tendency of Having MSH2 and MSH6 Microsatellite Instability among Clinicopathological Features in Patients with Colorectal Cancer
por: Arshita, Neni, et al.
Publicado: (2018)

A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report
por: Walker, Romy, et al.
Publicado: (2023)

Multiple functions for the N-terminal region of Msh6
por: Clark, Alan B., et al.
Publicado: (2007)

MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas
por: Micko, Alexander S. G., et al.
Publicado: (2017)

A Novel MSH6 Gene Variant in a Lynch Syndrome Patient with Lipomas
por: Giannoni, Ana Paula, et al.
Publicado: (2023)

BRCA1 testing
por: Górski, Bohdan, et al.
Publicado: (2008)

Principles of genetic predisposition to malignancies
por: Dębniak, Tadeusz, et al.
Publicado: (2008)

MSH2–MSH6 stimulates DNA polymerase η, suggesting a role for A:T mutations in antibody genes
por: Wilson, Teresa M., et al.
Publicado: (2005)

Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients
por: Petersen, Sanne M, et al.
Publicado: (2013)

Modulation of the DNA-binding activity of Saccharomyces cerevisiae MSH2–MSH6 complex by the high-mobility group protein NHP6A, in vitro
por: Labazi, Mohamed, et al.
Publicado: (2009)

The properties of Msh2–Msh6 ATP binding mutants suggest a signal amplification mechanism in DNA mismatch repair
por: Graham, William J., et al.
Publicado: (2018)

An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma
por: Javeed, Saira, et al.
Publicado: (2022)

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers
por: Sjursen, Wenche, et al.
Publicado: (2010)

Muir-Torre Syndrome Presenting as Sebaceous Adenocarcinoma and Invasive MSH6-Positive Colorectal Adenocarcinoma
por: Tulpule, Sunil, et al.
Publicado: (2016)

Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity
por: Houlleberghs, Hellen, et al.
Publicado: (2017)

An MSH6 germline pathogenic variant p.Gly162Ter associated with Lynch syndrome
por: Vostrukhina, Olga A., et al.
Publicado: (2022)

Functional in silico analysis of missense mutations in the MSH6 gene
por: Gajdel, Katarzyna, et al.
Publicado: (2015)

Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic MSH2 and MSH6 Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LS
por: Vogelaar, Ingrid P., et al.
Publicado: (2022)

Examination of Msh6- and Msh3-deficient Mice in Class Switching Reveals Overlapping and Distinct Roles of MutS Homologues in Antibody Diversification
por: Li, Ziqiang, et al.
Publicado: (2004)

Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
por: Ramsoekh, Dewkoemar, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_n7tm7v5fglrtua9r95s1pk3m51